Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
60.13
+1.97 (3.39%)
Nov 4, 2024, 4:00 PM EST - Market closed
Korro Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 42.67 | 36.54 | 21.39 | 14.06 |
| Research & Development | 48.95 | 48 | 37.61 | 21.43 |
| Operating Expenses | 91.62 | 84.53 | 59 | 35.49 |
| Operating Income | -91.62 | -84.53 | -59 | -35.49 |
| Other Non Operating Income (Expenses) | 6.37 | 3.39 | 0.98 | 13.54 |
| Pretax Income | -85.25 | -81.15 | -58.02 | -21.96 |
| Income Tax Expense | 0.05 | 0.03 | 0.01 | 0 |
| Net Income | -85.3 | -81.17 | -58.03 | -21.96 |
| Net Income to Common | -85.3 | -81.17 | -58.03 | -21.96 |
| Shares Outstanding (Basic) | 6 | 2 | 0 | 4 |
| Shares Outstanding (Diluted) | 6 | 2 | 0 | 4 |
| Shares Change (YoY) | -0.02% | 499.32% | -94.26% | - |
| EPS (Basic) | -15.11 | -53.08 | -227.42 | -4.94 |
| EPS (Diluted) | -15.11 | -53.08 | -227.42 | -4.94 |
| Free Cash Flow | -82.84 | -75.12 | -58.86 | -36.54 |
| Free Cash Flow Per Share | -14.68 | -49.12 | -230.65 | -8.22 |
| EBITDA | -88.27 | -80.9 | -56.49 | -33.9 |
| D&A For EBITDA | 3.35 | 3.63 | 2.51 | 1.6 |
| EBIT | -91.62 | -84.53 | -59 | -35.49 |
Source: S&P Capital IQ. Standard template.
Financial Sources.